Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    -15.00 (-3.42%)
Bid:
426.00
Ask:
430.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Statement

21 Dec 2010 07:00

RNS Number : 3227Y
Zotefoams PLC
21 December 2010
 



21 December 2010

 

 

Zotefoams plc("Zotefoams" or "the Company")

 

Trading Update

 

Zotefoams, which manufactures and sells high-performance foams, today provides a trading update prior to the Company's financial year end on 31 December 2010.

 

Since the Interim Management Statement dated 22 October 2010, the business has once again performed in line with our expectations, with sales in the fourth quarter anticipated to be approximately 7% ahead of the same period in 2009. The Board therefore expects profit before tax and exceptional items for the year ending 31 December 2010 to be in line with market expectations, which are based on an accounting basis consistent with 2009.1

 

Overall sales growth for the year is expected to exceed 20%. Our Azote® product range has seen strong sales growth across all major geographic markets, particularly in Asia. HPP (High-Performance Polymer) segment sales are expected to be approximately 50% above 2009 levels. Prices for LDPE, our major raw material, have remained relatively stable during the second half of 2010.

 

The Company intends to announce its preliminary results for the year ending 31 December 2010 on Tuesday, 8 March 2011.

 

 

Enquiries:

Zotefoams plc

David Stirling, Managing Director

Clifford Hurst, Finance Director 

0208 664 1600

Financial Dynamics Limited

Ben Brewerton/John Dineen

0207 831 3113

 

 

 

 

1 As described in note 9 in our Interim Report, from 1 July 2010 our 30% shareholding in MuCell Extrusion LLC will be treated in accordance with IFRS 3 (revised). The assets and liabilities of MuCell from 1 July 2010 will be included in Zotefoams' consolidated statement of financial position with a deduction in equity as a non-controlling interest, for the 70% of MuCell's net assets, to reflect the shareholding in MuCell which Zotefoams does not own. The income statement for MuCell will be consolidated in Zotefoams' consolidated income statement with a deduction as a non-controlling interest below profit after tax of 70% of MuCell's profit after tax to reflect the shareholding in MuCell that Zotefoams does not own.

 

Our internal expectations are based on exchange rates at the date of this announcement

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTTMBRTMBTTBFM
Date   Source Headline
28th Apr 20204:39 pmRNSDisclosure of rights attached to equity shares
22nd Apr 20203:51 pmRNSDirector/PDMR Shareholding
16th Apr 202012:39 pmRNSDirector/PDMR Shareholding
14th Apr 20202:41 pmRNSDirector/PDMR Shareholding
8th Apr 20204:19 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSPreliminary Results
1st Apr 20207:00 amRNSNotice of Results
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNS2019 Summary, COVID-19 and Current Trading Update
23rd Mar 20207:00 amRNSDelayed Preliminary Results
19th Mar 20208:40 amRNSDirectorate Change
17th Mar 20209:49 amRNSHolding(s) in Company
12th Mar 20204:11 pmRNSDirector/PDMR Shareholding
10th Mar 20204:30 pmRNSNotice of Results
27th Feb 20203:00 pmRNSDirector Declaration
12th Feb 20209:24 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSYear-End Trading Update
16th Jan 20203:33 pmRNSHolding(s) in Company
13th Jan 20204:21 pmRNSDirector/PDMR Shareholding
27th Dec 20199:03 amRNSHolding(s) in Company
17th Dec 20199:34 amRNSDirector/PDMR Shareholding
13th Dec 20198:41 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSHolding(s) in Company
26th Nov 201910:39 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSDirector/PDMR Shareholding
15th Oct 20192:50 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20199:48 amRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20194:31 pmRNSHolding(s) in Company
9th Oct 20192:37 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSNew technology for recyclable packaging
8th Oct 20197:00 amRNSAppointment of Joint Broker
3rd Oct 20197:00 amRNSTrading Update
1st Oct 201911:47 amRNSDirector Declaration
16th Sep 20193:39 pmRNSDirector/PDMR Shareholding
6th Sep 201912:07 pmRNSSecond Price Monitoring Extn
6th Sep 201912:02 pmRNSPrice Monitoring Extension
27th Aug 201912:07 pmRNSSecond Price Monitoring Extn
27th Aug 201912:02 pmRNSPrice Monitoring Extension
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn
21st Aug 201912:02 pmRNSPrice Monitoring Extension
13th Aug 20193:26 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results
15th Jul 20194:31 pmRNSDirector/PDMR Shareholding
12th Jul 20193:51 pmRNSDirector/PDMR Shareholding
10th Jul 20194:22 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
12th Jun 20192:53 pmRNSDirector/PDMR Shareholding
4th Jun 20193:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.